Michigan Medicine is the only treatment center in Michigan and one of several dozen sites in the country to offer CAR T-cell immune-therapy for treating childhood leukemia.
How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.
A multidisciplinary meeting at Mott elevates pediatric cancer cases to dozens of experts. A new review finds it’s improving care and comforting families in the process.
The marriage of immune science and cancer research may improve survival rates for some individuals with rare cancers. A groundbreaking U-M scientist explains more.
More than half of children saw either partial or complete cancer remission in an international clinical trial — an "extraordinary success."
Children with brain tumors have had limited treatment options in the past compared with adults. A new research model brings new hope.